<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Products &#8211; Apicell</title>
	<atom:link href="https://www.apicells.com/products/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.apicells.com</link>
	<description>Production &#38; exploitation of mammalian cells</description>
	<lastBuildDate>Thu, 26 Mar 2026 11:46:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.5</generator>

<image>
	<url>https://www.apicells.com/wp-content/uploads/2023/11/cropped-cropped-APICELLS-Logo-B-32x32.png</url>
	<title>Products &#8211; Apicell</title>
	<link>https://www.apicells.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HeLa Nuclear Extracts (Not dialysed)</title>
		<link>https://www.apicells.com/product/hela-nuclear-extracts-not-dialysed/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Fri, 26 Apr 2019 09:12:46 +0000</pubDate>
				<guid isPermaLink="false">https://www.apicells.com/?post_type=product&#038;p=383</guid>

					<description><![CDATA[<p>Volume: from 150ul to 15ml. Concentration:~6mg/ml (Bradford). Hela Nuclear Extracts are prepared from fresh cells in exponential phase only (Viability&#62;95%). Preparation witout dialysis.</p>]]></description>
										<content:encoded><![CDATA[<p><strong>HeLa cell</strong><br>The HeLa cell line was established from an adenocarcinoma of the cervix in 1952. It is the first continuous human cell line.</p><p><strong>Quality Control</strong><br>Cultures are screened for the presence of bacteria, yeast, fungi and mycoplasma (DNA amplification). NBCS used in the culture medium is certified from New Zealand origin.</p><p><strong>HeLa Nuclear Extracts Production</strong><br>HeLa cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p><p>The Nuclear Extracts are prepared according to:<br>Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Nucleic Acids Res. 11, 1475-1489</p><p>Conc. Protein (Bradford) = +/- 6 mg/ml</p><p>No dialysis is performed during the preparation of this product. The preparation stopped after the ultra-centrifugation step. Buffer composition is then the same as the extraction buffer.</p><p><strong>Research Use</strong><br>Our HeLa Nuclear Extracts are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin.</p><p>Source of HDAC activity, transcription factors, chromatin proteins and histones.</p><p>Also suitable for use in:</p><ul class="wp-block-list"><li>separation by SDS-PAGE;</li><li>Gel Shift assays used for protein-DNA interactions studies;</li><li>HDAC assays;</li><li>positive control for Western Blot assays;</li><li><em>in vitro</em> splicing;</li><li>transcription factors studies;</li><li>cell division cycle and apoptosis studies;</li><li>spliceosome and other proteome studies (DNA ends, snRNP&#8217;s, DNA PKcs, &#8230;).</li></ul><p><strong>References</strong></p>
<ul><li><a href="https://academic.oup.com/nar/article/24/5/868/1044811 ">Laggerbauer, B., Lauber, J. and Lührmann, R. (1996). Identification of an RNA-dependent ATPase activity in mammalian U5 SnRNPs. Nucl. Ac. Res. 24, 868-875.</a></li>
<li><a href="https://www.researchgate.net/publication/15533571_b-Tropomyosin_Pre-mRNA_Folding_Around_a_Muscle-specific_Exon_Interferes_with_Several_Steps_of_Spliceosome_Assembly ">Sirand-Pugnet, P., Durosay, P., Clouet d&#8217;Orval, B., Brody, E., Marie, J. (1995). R-Tropomyosin pre-mRNA folding around a muscle-specific exon interferes with several steps of spliceosome assembly. J. Mol. Biol. 251, 591-602.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC148593/pdf/273494.pdf ">Gell, D. and Jackson, S. P. (1999). Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. Nucl. Ac. Res. 27, 3494-3502.</a></li>
<li><a href="http://cancerres.aacrjournals.org/content/59/11/2581.long ">Izzard, R.A., Jackson, S.P. and Smith, G.C.M. (1999). Competitive and non-competitive inhibition of the DNA-dependent protein kinase. Cancer Res. 59, 2581-2586.</a></li>
<li><a href="https://www.nature.com/articles/1202973 ">Lakin, N.D., Hann, B.C. and Jackson, S.P. (1999) The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of P53. Oncogene 68, 3989-3995.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17999/ ">Smith, G.C., Cary, R.B., Lakin, N.D., Hann, B.C., Teo, S._H., Chen, D.J. and Jackson, S.P. (1999) Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Natl. Acad. Sci. USA 96, 11134-11139.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84521/ ">Smith, G.C., d&#8217;Adda di Fagagna, F., Lakin, N.D. and Jackson, S.P. (1999) Cleavage and inactivation of ATM during apoptosis. Molec. Cell. Biol. 19, 6076-6084.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC102500/ ">Chew, S.L., Baginsky, L., Eperon, I.C. (2000) An exonic splicing silencer in the testes-specific DNA ligase III B exon. Nucleic Acid Res. 28, 402-410.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137431/ ">Deplus, R., Brenner, C., Burgers, W.A., Putmans, P., Kouzarides, T., de Launoit, Y., Fuks, F. (2002) Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acid Res. 30, n°17, 3831-3838.</a></li>
<li><a href="http://www.jbc.org/content/281/48/37159.long ">Hallay, H., Locker, N., Ayadi, L., Ropers, D., Guittet, E. and Branlant, C. (2006) Biochemical and NMR study on the competition between proteins SC35, SRp40 and hnRNP A1 at the HIV-1 Tat exon 2 splicing site. J. Biol. Chem., Vol. 281, Issue 48, 37159-37174</a></li>
<li><a href="https://www.academia.edu/22974112/Micro-scale_open-tube_capillary_separations_of_functional_proteins ">Hanna, C., Gjerde, D., Nguyen, L., Dickman, M., Brown, P. and Hornby, D. (2006) Micro-scale open-tube capillary separations of functional proteins. Analytical Biochemistry 350, 128-137.</a></li>
<li><a href="http://www.jbc.org/content/276/44/40464.long ">Jacquenet, S., Méreau, A., Bilodeau, P.S., Damier, L., Martin Stoltzfus, C. and Branlant, C. (2001) A Second Exon Splicing Silencer within Human Immunodeficiency Virus Type 1 tat Exon 2 Represses Splicing of Tat mRNA and Binds Protein hnRNP H*. J. Biol. Chem., 276, No 44, Issue of November 2, 40464-40475</a></li>
<li><a href="https://www.nature.com/articles/1208025 ">Roche,K.C., Wiechens,N., Owen-Hughes,T and Perkins, N.D. (2004) The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. Oncogene 23, 8185-8195</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064439/ ">Brandt, D., Marion, S., Griffiths, G., Watanabe, T., Kaibuchi, K. and Grosse, R. (2007) Dia 1 and IQGAP1 interact in cell migration and phagocytic cup formation. Journal of Cell Biology 178, 193-200</a></li>
<li><a href="http://www.jbc.org/content/279/29/29963.long ">Ropers, D., Ayadi, L., Gattoni, R., Jacquenet, S., Damier, L., Branlant, C. and Stévenin, J. (2004) Differential effects of the SR proteins 9G8, SC35, ASF/SF2 and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J. Biol. Chem., 279, 29963-29973</a></li>
<li><a href="https://www.sciencedirect.com/science/article/pii/S0092867409002566?via%3Dihub ">Gehring, N.H., Lamprinaki, S., Kulozik, A.E. and Hentze, M. (2009) Disassembly of exon junction complexes by PYM. Cell 137, 536-548</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682485/ ">Gehring, N.H., Lamprinaki, S., Hentze, M. and Kulozik, A.E. (2009) The hierarchy of exon-junction complex assembly by the spliceosome explains key features of mammalian nonsense-mediated mRNA decay. Plos Biology 7 (5) e 1000120</a></li>
<li><a href="https://www.embopress.org/cgi/doi/10.1038/sj.embor.7400847">Rivera-Calzada, A., Spagnolo, L., Laurence H., P., Llorca, O. (2007) Structural model of full-lengh human Ku70-Ku80 heterodimer and its recognition of DNA and DNA-PKcs. EMBO reports 8, 56-62</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946139/">Stefan Reber, Jolanda Stettler1, Giuseppe Filosa, Martino Colombo Daniel Jutzi, Silvia C Lenzken, Christoph Schweingruber, Rémy Bruggmann, Angela Bachi, Silvia ML Barabino, Oliver Mühlemann &amp; Marc-David Ruepp (2016) Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. The EMBO Journal 35: 1504–1521</a></li>
<li><a href="https://www.sciencedirect.com/science/article/pii/S1534580714005565">JiwenYang, Lee-HsuehHung, ThomasLicht, SawaKostin, MarioLooso, EkaterinaKhrameeva, AlbrechtBindereif, AndreSchneider, ThomasBraun. (2014) RBM24 Is a Major Regulator of Muscle-Specific Alternative Splicing. Developmental Cell Volume 31, Issue 1, 13 October 2014, Pages 87-99</a></li>
<li><a href="https://academic.oup.com/nar/article/44/10/4721/2516100">Vivien Berthelot, Gildas Mouta-Cardoso, Nadia Hégarat, François Guillonneau, Jean-Christophe François, Carine Giovannangeli, Danièle Praseuth, Filippo Rusconi. (2016) The human DNA ends proteome uncovers an unexpected entanglement of functional pathways. Nucleic Acids Research, Volume 44, Issue 10, 2 June 2016, Pages 4721–4733</a></li>
<li><a href="https://academic.oup.com/nar/article/43/20/9711/1399477">Katarzyna Dorota Raczynska Marc-David Ruepp Aleksandra Brzek Stefan Reber Valentina Romeo Barbara Rindlisbacher Manfred Heller Zofia Szweykowska-Kulinska Artur Jarmolowski Daniel Schümperli. (2015) FUS/TLS contributes to replication-dependent histone gene expression by interaction with U7 snRNPs and histone-specific transcription factors. Nucleic Acids Research, Volume 43, Issue 20, 16 November 2015, Pages 9711–9728</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980667/">Tim Schneider, Lee-Hsueh Hung, Silke Schreiner, Stefan Starke, Heinrich Eckhof , Oliver Rossbach, Stefan Reich, Jan Medenbach, and Albrecht Bindereif. (2016) CircRNA-protein complexes: IMP3 protein component defines subfamily of circRNPs. Nature Sci Rep. 2016; 6: 31313.</a></li>
<li><a href="http://europepmc.org/articles/pmc4601338">Andri Christodoulou and Hideki Yokoyama. (2015) Purification of nuclear localization signal-containing proteins and its application to investigation of the mechanisms of the cell division cycle. Small GTPases. 2015 Jan-Mar; 6(1): 20–27</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282561/">Lorenzo Lafranchi, Harmen R de Boer, Elisabeth GE de Vries, Shao-En Ong, Alessandro A Sartori and Marcel ATM van Vugt. (2014) APC/CCdh1 controls CtIP stability during the cell cycle and in response to DNA damage. EMBO J. 2014 Dec 1; 33(23): 2860–2879.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338599/">Takashi Ochi, Andrew N. Blackford, Julia Coates, Satpal Jhujh, Shahid Mehmood, Naoka Tamura, Jon Travers, Qian Wu, Viji M. Draviam, Carol V. Robinson, Tom L. Blundell, and Stephen P. Jackson (2015) PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science. 2015 Jan 9; 347(6218): 185–188.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374139/">Andrew N. Blackford, Jadwiga Nieminuszczy, Rebekka A. Schwab, Yaron Galanty, Stephen P. Jackson, and Wojciech Niedzwiedz (2015) TopBP1 Interacts with BLM to Maintain Genome Stability but Is Dispensable for Preventing BLM Degradation. Mol Cell. 2015 Mar 19; 57(6): 1133–1141</a></li></ul>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>CV-1 Cytoplasmic Extracts</title>
		<link>https://www.apicells.com/product/cv-1-cytoplasm/</link>
					<comments>https://www.apicells.com/product/cv-1-cytoplasm/#comments</comments>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Fri, 02 Mar 2018 11:43:29 +0000</pubDate>
				<guid isPermaLink="false">http://www.apicells.com/?post_type=product&#038;p=357</guid>

					<description><![CDATA[CV-1 cell line This is a pseudodiploid, male African green monkey cell line. The modal chromosome number was 60, occurring in 48% of cells, and the rate of polyploidy was at 4.4%. Only a few markers were found., Of these M1, a probable deleted N11, was found in all cells examined; M3 of unknown origin [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><strong>CV-1 cell line</strong><br />
This is a pseudodiploid, male African green monkey cell line. The modal chromosome number was 60, occurring in 48% of cells, and the rate of polyploidy was at 4.4%. Only a few markers were found., Of these M1, a probable deleted N11, was found in all cells examined; M3 of unknown origin was in some cells; and the remaining 2 to 3 others of unknown origins were found only once., N11 was uniformly single copied, and N16 was also single copied in most cells. Both X and Y chromosomes were also detected in every cell.<br />
Derivation<br />
The CV-1 cell line was derived from the kidney of a male adult African green monkey by F.C. Jensen, et al. in March, 1964 for use in Rous sarcoma virus transformation studies.</p>
<p><strong>CV-1 Nuclei Production</strong><br />
CV-1 cells are grown in cell-factories under GLP conditions in our facility in Mons, Belgium.</p>
<p>Nuclei are prepared by low speed centrifugation, rinsed with phosphate buffer saline. After exposure to hypotonic buffer, nuclei are separated from cytoplasm and membrane using dounce and centrifugation. Cytoplasm is then snap frozen in liquid nitrogen and stored at -85°C.</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification).</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.apicells.com/product/cv-1-cytoplasm/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>CV-1 Nuclei</title>
		<link>https://www.apicells.com/product/cv-1-nuclei/</link>
					<comments>https://www.apicells.com/product/cv-1-nuclei/#respond</comments>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Fri, 02 Mar 2018 11:35:37 +0000</pubDate>
				<guid isPermaLink="false">http://www.apicells.com/?post_type=product&#038;p=353</guid>

					<description><![CDATA[CV-1 cell line This is a pseudodiploid, male African green monkey cell line. The modal chromosome number was 60, occurring in 48% of cells, and the rate of polyploidy was at 4.4%. Only a few markers were found., Of these M1, a probable deleted N11, was found in all cells examined; M3 of unknown origin [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><strong>CV-1 cell line</strong><br />
This is a pseudodiploid, male African green monkey cell line. The modal chromosome number was 60, occurring in 48% of cells, and the rate of polyploidy was at 4.4%. Only a few markers were found., Of these M1, a probable deleted N11, was found in all cells examined; M3 of unknown origin was in some cells; and the remaining 2 to 3 others of unknown origins were found only once., N11 was uniformly single copied, and N16 was also single copied in most cells. Both X and Y chromosomes were also detected in every cell.<br />
Derivation<br />
The CV-1 cell line was derived from the kidney of a male adult African green monkey by F.C. Jensen, et al. in March, 1964 for use in Rous sarcoma virus transformation studies.</p>
<p><strong>CV-1 Nuclei Production</strong><br />
CV-1 cells are grown in cell-factories under GLP conditions in our facility in Mons, Belgium.</p>
<p>Nuclei are prepared by low speed centrifugation, rinsed with phosphate buffer saline. After exposure to hypotonic buffer, nuclei are separated from cytoplasm and membrane using dounce and centrifugation. Nuclei are then snap frozen in liquid nitrogen and stored at -85°C.</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification).</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.apicells.com/product/cv-1-nuclei/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CV-1 Cells Pellets</title>
		<link>https://www.apicells.com/product/cv-1-cells-pellets/</link>
					<comments>https://www.apicells.com/product/cv-1-cells-pellets/#respond</comments>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Mon, 19 Feb 2018 14:34:34 +0000</pubDate>
				<guid isPermaLink="false">http://www.apicells.com/?post_type=product&#038;p=346</guid>

					<description><![CDATA[CV-1 cell line This is a pseudodiploid, male African green monkey cell line. The modal chromosome number was 60, occurring in 48% of cells, and the rate of polyploidy was at 4.4%. Only a few markers were found., Of these M1, a probable deleted N11, was found in all cells examined; M3 of unknown origin [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><strong>CV-1 cell line</strong><br />
This is a pseudodiploid, male African green monkey cell line. The modal chromosome number was 60, occurring in 48% of cells, and the rate of polyploidy was at 4.4%. Only a few markers were found., Of these M1, a probable deleted N11, was found in all cells examined; M3 of unknown origin was in some cells; and the remaining 2 to 3 others of unknown origins were found only once., N11 was uniformly single copied, and N16 was also single copied in most cells. Both X and Y chromosomes were also detected in every cell.<br />
Derivation<br />
The CV-1 cell line was derived from the kidney of a male adult African green monkey by F.C. Jensen, et al. in March, 1964 for use in Rous sarcoma virus transformation studies.</p>
<p><strong>CV-1 cells&nbsp;Production</strong><br />
CV-1 cells are grown in cell-factories under GLP conditions in our facility in Mons, Belgium.</p>
<p>Cell pellets are prepared by low speed centrifugation, rinsed with phosphate buffer saline, snap frozen in liquid nitrogen and stored at -85°C.</p>
<p>The cell pellets are not prepared in aseptic conditions and are not intended to be used as seed for a new culture.</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification).</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.apicells.com/product/cv-1-cells-pellets/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>HeLa Nuclei</title>
		<link>https://www.apicells.com/product/hela-nuclei/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Thu, 13 Apr 2017 12:24:14 +0000</pubDate>
				<guid isPermaLink="false">http://new.apicells.com/?post_type=product&#038;p=160</guid>

					<description><![CDATA[<p>Hela cells pellets harvest in exponential phase and Nuclei are prepared from fresh cells only.</p>]]></description>
										<content:encoded><![CDATA[<p><strong>HeLa cell</strong><br>The HeLa cell line was established from an adenocarcinoma of the cervix in 1952. It is the first continuous human cell line.</p>
<p><strong>Quality Control</strong><br>Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification). NBCS used in the culture medium is certified from New Zealand origin.</p>
<p><strong>HeLa Nuclei Production</strong><br>HeLa cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p><strong>Research Use</strong><br>Our HeLa Nuclei are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin.</p>
<p>Also suitable for use in:</p>
<ul>
<li>entities production and purification of biological material from human origin used in many other applications (as core histones used in HAT assays);</li>
<li>Gel Shift and Western Blotting assay;</li>
<li>biochemical processing;</li>
<li>nucleic acid purification and research;</li>
<li>protein expression studies;</li>
<li><em>in vitro</em> activity assays.</li>
</ul><p><strong>References</strong></p>
<ul><li><a href="https://www.sciencedirect.com/science/article/pii/S1097276504004459?via%3Dihub ">Azubel, M., Wolf, S.G., Sperling, J. and Sperling, R. (2004) Three-dimensional structure of the native spliceosome by cryo-electron microscopy. Molec. Cell. 15, 833-839</a></li>
<li><a href="https://www.jimmunol.org/content/179/11/7568.long ">Hoffmann,M.H., Tuncel,J., Shriner,K., Tohidast-Akrad, M.Türk;B., Pinol-Roma,S., Serre, G., Schett,G., Smolen,J ;S., Holmdahl,R. and Steiner,G. (2007) The Rheumatoid Arthritis-Associated Autoantigen hnRNP-A2 (RA33) is a Major Stimulation of Autoimmunity in Rats with Pristane-induced Arthritis. The Journal of Immunology 179, 7568-7576</a></li></ul><p></p>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>K562 Cell Pellets</title>
		<link>https://www.apicells.com/product/k562-cell-pellets/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Thu, 13 Apr 2017 12:21:43 +0000</pubDate>
				<guid isPermaLink="false">http://new.apicells.com/?post_type=product&#038;p=157</guid>

					<description><![CDATA[Our cells pellets are produced from cells harvest in exponential phase.]]></description>
										<content:encoded><![CDATA[<p><strong>K562 cell</strong><br />
The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises.<br />
The cell population has been characterized as highly undifferentiated and of the granulocytic series.<br />
Studies conducted by Anderson, et al., on the surface membrane properties led to the conclusion that the K-562 was a human erythroleukemia line. The K-562 cell line has attained widespread use as a highly sensitive in vitro target for the natural killer assay.<br />
See Pross, et al. for a detailed analysis of the in vitro assay of NK cells including the mathematics of quantitation of NK cell activity.<br />
K-562 blasts are multipotential, hematopoietic malignant cells that spontaneously differentiate into recognizable progenitors of the erythrocytic, granulocytic and monocytic series.<br />
The effect of inducers on sublines derived from the original K-562 cell line have been reviewed by Koeffler and Golde. Cultures from the ATCC stock have been shown to exhibit this sensitivity for assessing human natural killer activity.<br />
Karyological studies on various K-562 sublines have been classified into three groups (A,B,C) by Dimery, et al.<br />
The strain obtained by the ATCC most closely resembles the B population. Occurrence of the Philadelphia chromosome, however, was of much lower frequency; none detected in 15 metaphases examined.</p>
<p><strong>K562 cells Production</strong><br />
K562 cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p>Cell pellets are prepared by low speed centrifugation, rinsed with phosphate buffer saline, snap frozen in liquid nitrogen and stored at -85°C.</p>
<p>The cell pellets are not prepared in aseptic conditions and are not intended to be used as seed for a new culture.</p>
<p><strong>Research Use Only</strong><br />
Our K562 cell pellets are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin. For published papers reporting the use of our extract, please check out our references list</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification). Sera used in the culture medium are CE certified from South American origin.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>HUT-78 Cell Pellets</title>
		<link>https://www.apicells.com/product/hut-78-cell-pellets/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Thu, 13 Apr 2017 12:18:18 +0000</pubDate>
				<guid isPermaLink="false">http://new.apicells.com/?post_type=product&#038;p=154</guid>

					<description><![CDATA[Our cells pellets are produced from cells harvest in exponential phase.]]></description>
										<content:encoded><![CDATA[<p><strong>HUT-78 cell</strong><br />
Derived from the peripheral blood of a patient with Sezary syndrome. The line has the properties of a mature human T cell with helper/inducer activity. It releases IL-2 and has receptors for IL-2. The growth rate is stimulated by IL-2. TNF alpha is an autocrine growth factor for HUT-78.</p>
<p><strong>HUT-78 cells&nbsp;Production</strong><br />
HUT-78 cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p>Cell pellets are prepared by low speed centrifugation, rinsed with phosphate buffer saline, snap frozen in liquid nitrogen and stored at -85°C.</p>
<p>The cell pellets are not prepared in aseptic conditions and are not intended to be used as seed for a new culture.</p>
<p><strong>Research Use Only</strong><br />
Our HUT-78 cell pellets are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin. For published papers reporting the use of our extract, please check out our references list</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification). Sera used in the culture medium are CE certified from South American origin.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>U937 Cell Pellets</title>
		<link>https://www.apicells.com/product/u937-cell-pellets/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Thu, 13 Apr 2017 12:18:04 +0000</pubDate>
				<guid isPermaLink="false">http://new.apicells.com/?post_type=product&#038;p=151</guid>

					<description><![CDATA[Our cells pellets are produced from cells harvest in exponential phase.]]></description>
										<content:encoded><![CDATA[<p><strong>U937 cell</strong><br />
U-937 cells are a model cell line used in biomedical research. They were isolated from the histiocytic lymphoma of a 37 year old male patient and are used to study the behaviour and differentiation of monocytes. U937 cells mature and differentiate in response to a number of soluble stimuli, adopting the morphology and characteristics of mature macrophages.</p>
<p><strong>U937 cells&nbsp;Production</strong><br />
U937 cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p>Cell pellets are prepared by low speed centrifugation, rinsed with phosphate buffer saline, snap frozen in liquid nitrogen and stored at -85°C.</p>
<p>The cell pellets are not prepared in aseptic conditions and are not intended to be used as seed for a new culture.</p>
<p><strong>Research Use Only</strong><br />
Our U937 cell pellets are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin. For published papers reporting the use of our extract, please check out our references list</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification). Sera used in the culture medium are CE certified from South American origin.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>L363 Cell Pellets</title>
		<link>https://www.apicells.com/product/l363-cell-pellets/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Thu, 13 Apr 2017 12:14:56 +0000</pubDate>
				<guid isPermaLink="false">http://new.apicells.com/?post_type=product&#038;p=148</guid>

					<description><![CDATA[Our cells pellets are produced from cells harvest in exponential phase.]]></description>
										<content:encoded><![CDATA[<p><strong>L363&nbsp;cell</strong><br />
Human plasma cell leukemia established from the peripheral blood of a 36-year-old woman with plasma cell leukemia (IgG) in 1977; cells were described to be EBNA-negative and to express mRNA for proto-oncogene bcl-2 confirmed as human with IEF of AST, LDH, PEP B.</p>
<p><strong>L363&nbsp;cells&nbsp;Production</strong><br />
L363&nbsp;cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p>Cell pellets are prepared by low speed centrifugation, rinsed with phosphate buffer saline, snap frozen in liquid nitrogen and stored at -85°C.</p>
<p>The cell pellets are not prepared in aseptic conditions and are not intended to be used as seed for a new culture.</p>
<p><strong>Research Use Only</strong><br />
Our L363 cell pellets are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin. For published papers reporting the use of our extract, please check out our references list</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification). Sera used in the culture medium are CE certified from South American origin.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>BV173 Cell Pellets</title>
		<link>https://www.apicells.com/product/bv173-cell-pellets/</link>
		
		<dc:creator><![CDATA[Florent Rullière]]></dc:creator>
		<pubDate>Thu, 13 Apr 2017 10:12:47 +0000</pubDate>
				<guid isPermaLink="false">http://new.apicells.com/?post_type=product&#038;p=128</guid>

					<description><![CDATA[Our cells pellets are produced from cells harvest in exponential phase.]]></description>
										<content:encoded><![CDATA[<p><strong>BV173 cell</strong><br />
The BV173 cell line was established from&nbsp;a B cell precursor leukemia.</p>
<p><strong>BV173 cells&nbsp;Production</strong><br />
BV173 cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p>Cell pellets are prepared by low speed centrifugation, rinsed with phosphate buffer saline, snap frozen in liquid nitrogen and stored at -85°C.</p>
<p>The cell pellets are not prepared in aseptic conditions and are not intended to be used as seed for a new culture.</p>
<p><strong>Research Use Only</strong><br />
Our BV173 cell pellets are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin. For published papers reporting the use of our extract, please check out our references list</p>
<p><strong>Quality Control</strong><br />
Cultures are screened for the presence of bacteries, yeast, fungi and mycoplasma (DNA amplification). Sera used in the culture medium are CE certified from South American origin.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
